SMGNYSEAgricultural ChemicalsFiscal year ends September 30
SCOTTS MIRACLE-GRO CO
Financials through Q3 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Aug 5, 2026
$54.39−0.18 (-0.33%)
Close on Oct 19, 2026
- Market cap
- $3.22B
- P/E (TTM)
- 45.0
- Dividend yield
- 4.85%
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
30.6%−2.0 pts over 5 years
Operating margin
10.5%−3.7 pts over 5 years
Net margin
4.3%−5.1 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -3.9% | -4.5% | -3.7% | +3.7% | |
| Gross profit | +22.8% | +6.2% | -5.0% | +2.6% | |
| Operating income | +71.7% | – | -9.3% | +3.5% | |
| Net income | – | – | -17.8% | -1.0% | |
| EPS, diluted | – | – | -18.4% | -0.4% | |
| Free cash flow | -53.1% | – | -11.2% | +4.0% | |
| Dividend per share | 0.0% | 0.0% | -18.5% | +3.8% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 47.2% | 54.7% | -38.8% | |
| Return on assets | 11.9% | 12.1% | 5.2% | |
| Current ratio | 1.46 | 1.28 | 1.27 | |
| Debt to equity | 1.70 | 2.18 | -5.89 | |
| Net debt to EBITDA | 2.33× | 2.21× | – | |
| Interest coverage | 7.1× | 7.4× | 2.8× | |
| Inventory turnover | 4.1× | 4.8× | 4.2× | |
| Capex to revenue | 2.3% | 1.5% | 2.9% | |
| Diluted shares | 62M | 57M | 59M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Scotts Miracle-Gro generated $1.97B from operations and spent $1.68B on capital expenditure, dividends and share buybacks. 29% of that went back into the business.
Generated
$1.97B
Used
$1.68B
Capital expenditure$494.60M29%Dividends$763.90M46%Share buybacks$420.00M25%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin4.3%
×Asset turnover1.22×
×Equity multiplier-7.50×
=Return on equity, FY2025-38.8%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 4.3% | 1.22× | -7.50× | -38.8% |
| FY2024 | -1.0% | 1.13× | -9.55× | 10.6% |
| FY2021 | 10.4% | 1.20× | 4.78× | 59.9% |
| FY2020 | 9.4% | 1.29× | 4.53× | 54.7% |
| FY2019 | 14.6% | 1.04× | 5.67× | 85.8% |
| FY2018 | 2.4% | 0.92× | 5.78× | 12.7% |
| FY2017 | 8.3% | 0.96× | 4.03× | 32.0% |
| FY2016 | 12.6% | 0.95× | 3.95× | 47.2% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
7of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero$145.20M
- Cash generatingOperating cash flow above zero$371.30M
- Return on assets improvedROA up on the prior year-1.0% → 5.1%
- Earnings backed by cashOperating cash flow above net income$371.30M vs $145.20M
- Less leverageLong-term debt to assets fell75.7% → 74.7%
- Better liquidityCurrent ratio rose1.31 → 1.27
- No dilutionShare count did not rise57M → 59M
- Gross margin improvedGross margin up on the prior year23.94% → 30.59%
- More efficientAsset turnover rose1.04 → 1.19